Full Papers
Fibromyalgia in patients with rheumatoid arthritis. A 10-year follow-up study, results from the Oslo Rheumatoid Arthritis Register
S.A. Provan1, C. Austad2, V. Halsaa3, H.B. Hammer4, T.K. Kvien5, T. Uhlig6
- Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. sellaprovan@gmail.com
- Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
- Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
- Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
- Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
- Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
CER11523
2019 Vol.37, N°1 ,Suppl.116
PI 0058, PF 0062
Full Papers
Free to view
(click on article PDF icon to read the article)
PMID: 30620293 [PubMed]
Received: 15/07/2018
Accepted : 05/11/2018
In Press: 08/01/2019
Published: 08/02/2019
Abstract
OBJECTIVES:
To examine cross-sectional and longitudinal relationships between fibromyalgia (FM) and rheumatoid arthritis (RA) disease activity.
METHODS:
636 patients in the observational Oslo RA register (ORAR) were invited to a clinical examination in 1999. 28-tender and swollen joint counts (TJC, SJC) and 18-tender points were assessed, the RA disease activity score (DAS-28) calculated. Fibromyalgia (FM) was diagnosed according to 1990 (FM-1990) and modified 2011 (mFM-2011) ACR criteria. At the 10-year follow-up patients completed the RA Disease Activity Index (RADAI) and Routine Assessment of Patient Index Data 3 (RAPID-3). Baseline and 10-year RA disease activity were compared across presence/absence of FM. Linear regression models were constructed with 10-year RADAI and RAPID-3 as outcome.
RESULTS:
502 patients participated at baseline data-collection and 10-year data was available in 236. At baseline, mean (SD) age was 59.5 (12.5) years and 87% were female. 9% and 30% had FM-1990 and mFM-2011 respectively. RA-FM patients were predominantly female with higher SJC, TJC, and DAS-28 at baseline. Baseline RA-FM predicted higher levels of RADAI and RAPID-3 at the 10-year follow-up.
CONCLUSIONS:
RA-FM was associated with significantly higher levels of cross-sectional and longitudinal RA disease activity. FM should be considered in patients with RA not reaching remission.